CVS Stock Chart & Stats
$1870.00
$20.00(1.08%)
At close: 4:00 PM EDT
$1870.00
$20.00(1.08%)
Day’s Range― - ―
52-Week Range$1,125.00 - $2,000.00
Previous CloseN/A
Volume13.00
Average Volume (3M)221.00
Market Cap
$2.38T
Enterprise Value$158.57K
Total Cash (Recent Filing)$11.80B
Total Debt (Recent Filing)$78.34B
Price to Earnings (P/E)47.3
Beta-0.21
Next Earnings
Aug 05, 2026EPS Estimate
32.29Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.31
Shares Outstanding1,275,927,200
10 Day Avg. Volume601
30 Day Avg. Volume221
Financial Highlights & Ratios
PEG Ratio-0.92
Price to Book (P/B)1.34
Price to Sales (P/S)0.25
P/FCF Ratio12.88
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$1,939.46Price Target Upside3.71% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering17
EPS Forecast (FY)129.97
Revenue Forecast (FY)$7.14T
Bulls Say, Bears Say
Bulls Say
Vertically Integrated Business ModelCVS’s ownership of insurance (Aetna), PBM (Caremark) and retail pharmacy creates durable synergies: it can steer volume across channels, coordinate care and medication adherence, and capture cross-segment economics. That integration supports member retention, revenue stability and long-run cost management.
Solid Cash GenerationConsistent operating and free cash flow provide structural flexibility to fund deleveraging, invest in technology and care delivery, and sustain dividends. Even with profit pressure, strong cash conversion improves resilience to cyclical medical costs and funds multi-year strategic initiatives like Health100 and Oak Street expansion.
Scale And Aetna Margin ImprovementImproving medical benefit ratio and material AOI gains at Aetna show operational leverage within the benefits business. Scale across millions of members enhances negotiating power and care-management ROI, making margin recovery plausible and supporting sustainable earnings improvement as cost controls and care delivery initiatives scale.
Bears Say
Compressed Profitability And ReturnsMaterial margin and ROE deterioration erodes the company’s earnings power and reduces internal funding capacity. If compressed margins persist, free cash flow and ability to reinvest or accelerate deleveraging will be constrained, limiting long-term return on the sizable equity and asset base despite revenue growth.
PBM Rebate & Client Price PressuresStructural headwinds in PBM economics — rebate guarantees, client price concessions and evolving contracting — can sustainably compress pharmacy services margins. Given PBM’s role in earnings, prolonged pressure or regulatory-driven changes to rebate models would materially reduce segment profitability and enterprise operating income.
Elevated Medical Cost TrendsPersistently higher medical cost trends increase claims expense for the insurance business and pressure benefit margins. Even with operational fixes, elevated trend assumptions raise the baseline cost of providing coverage, making sustained margin recovery harder and introducing multi-period earnings volatility for Health Care Benefits.
CVS Health News
CVS FAQ
What was CVS Health Corp’s price range in the past 12 months?
CVS Health Corp lowest stock price was $1125.00 and its highest was $2000.00 in the past 12 months.
What is CVS Health Corp’s market cap?
CVS Health Corp’s market cap is $2.38T.
When is CVS Health Corp’s upcoming earnings report date?
CVS Health Corp’s upcoming earnings report date is Aug 05, 2026 which is in 6 days.
How were CVS Health Corp’s earnings last quarter?
CVS Health Corp released its earnings results on May 06, 2026. The company reported $44.829 earnings per share for the quarter, beating the consensus estimate of $38.096 by $6.733.
Is CVS Health Corp overvalued?
According to Wall Street analysts CVS Health Corp’s price is currently Undervalued.
Does CVS Health Corp pay dividends?
CVS Health Corp does not currently pay dividends.
What is CVS Health Corp’s EPS estimate?
CVS Health Corp’s EPS estimate is 32.29.
How many shares outstanding does CVS Health Corp have?
CVS Health Corp has 1,275,927,200 shares outstanding.
What happened to CVS Health Corp’s price movement after its last earnings report?
CVS Health Corp reported an EPS of $44.829 in its last earnings report, beating expectations of $38.096. Following the earnings report the stock price went up 7.041%.
Which hedge fund is a major shareholder of CVS Health Corp?
Currently, no hedge funds are holding shares in MX:CVS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CVS Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$1,939.46 (3.71% Upside)
$1,939.46 (3.71% Upside)
Blogger Sentiment
Bullish
MX:CVS Sentiment 80%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth $323.7M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
89.21%
12-Months-Change
Fundamentals
Return on Equity
2.43%
Trailing 12-Months
Asset Growth
-1.02%
Trailing 12-Months
Company Description
CVS Health Corp
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
CVS Company Deck
CVS Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a generally positive tone driven by clear top-line growth, strong cash generation, profit and EPS beats, an upward revision to full-year EPS guidance, meaningful improvement at Aetna (material AOI gain and operational efficiencies), and ongoing technology/AI initiatives (Health100). Offsetting risks include segment-level profit declines (Health Services and PCW), membership impacts from the Individual Exchange exit, continued elevated medical cost trends, PBM rebate pressures and regulatory/state-level uncertainty. On balance, the favorable operating metrics, raised guidance, and credible path to margin recovery outweighed the identifiable challenges.View all MX:CVS earnings summariesCVS Revenue Breakdown
46.57% Health Services
35.05% Health Care Benefits
33.40% Pharmacy & Consumer Wellness
0.12% Corporate/ Other
CVS Stock 12 Month Forecast
Average Price Target
$1,939.46
▲(3.71% Upside)